AVTXAvalo Therapeutics, Inc.

$6.93-56% 1Y
Latest close: a new 52-week lowOct 23, 2026what changed →

Is it safe?

Watch

Caution warranted: heavy debt (CCC) and big price swings.

2 to watch, 4 without data
Credit gradeCCCderived · Jun 30, 2026

Debt against weak or negative operating profit. A rule of thumb on leverage, not a credit rating.

Drawdown risk90% volderived · Oct 23, 2026

Large price swings, high volatility. Worst drawdown -100% · now 70% below its 52-week high.

Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.

Can AVTX take a bad year?

The deepest fall in AVTX's price history on file is −100%; it is 70% below its high today.

−100%

Worst drawdown on file · −70% today

Annualised volatility
90%

Annualised volatility · S&P 500 16% · about 5 times the market's own swing

Details›
Cash and short-term investments
$400M
EBITDA, trailing twelve months
−$91M
Operating profit, trailing twelve months
−$91M
Annualised volatilitytwo years of daily moves
90%
Worst drawdown on file
−100%
Below its 52-week high
70%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.

How far can it fall?

How much the price moves, how deep and how long its falls have run, and what each unit of risk has paid.